A possible mechanism for host-specific pathogenesis of Salmonella serovars

Microbial Pathogenesis

Volumn 21, Issue 6, 1996, Pages 435-446

  Ishibashi, Yoshio ^a   Arai, Toshihiko ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Complement receptor; Host specific pathogenesis; Intracellular survival; Macrophage; Salmonella typhi; Salmonella typhimurium

Indexed keywords

COMPLEMENT RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; SEROTYPE;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE; SALMONELLA; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0030540989     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1996.0074     Document Type: Article

References (56)

1. Mackaness GB, Blanden RV, Collins FM. Host-parasite relations of mouse typhoid. J Exp Med 1966; 124: 573-583.
2. O'Brien AD. Innate resistance of mice to Salmonella typhi infection. Infect Immun 1982; 38: 948-952.
3. Lissner CR, Weinstein DL, O'Brien AD. Mouse chromosome 1 Ity locus regulates microbicidal activity of isolated peritoneal macrophages against a diverse group of intracelluar and extracellular bacteria. J Immunol 1985; 135: 544-547.
4. Fields PI, Swanson RV, Haidaris CG, Heffron F. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc Natl Acad Sei USA 1986; 83: 5189-5193.
5. Ishibashi Y, Arai T. Susceptibility of Salmonella typhimurium and Salmonella typhi to oxygen metabolites. FEMS Microbiol Immunol 1989; 47: 279-284.
6. Ishibashi Y, Arai T. Specific inhibition of phagosome-lysosome fusion in murine macrophages mediated by Salmonella typhimurium infection. FEMS Microbiol Immunol 1990; 64: 35-44.
7. Buchmeier NA, Heffron F. Inhibition of phagosome-lysosome fusion by Salmonella typhimurium. Infect Immun 1991; 59: 2332-2338.
8. Aranda CMA, Swanson JA, Loomis WP, Miller SI. Salmonella typhimurium activates virulence gene transcription within acidified macrophage phagosomes. Proc Natl Acad Sei USA 1992; 89: 10079-10083.
9. Fields PI, Groisman EA, Heffron FA. Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells. Science 1989; 243: 1059-1062.
10. Hart PH, Spencer LK, Nikoloutsopoulos A, Lopez AF, Vadas MA, McDonald PJ, Finlay-Jones JJ. Role of cell surface receptors in the regulation of intracellular killing of bacteria by murine peritoneal exudate neutrophils. Infect Immun 1986; 52: 245-251.
11. Wilson ME, Pearson RD. Roles of CR3 and mannose receptors in the attachment and ingestion of Leishmania donovani by human mononuclear phagocytes. Infect Immun 1988; 56: 363-369.
12. Mosser DM, Vlassara H, Edelson PJ, Crerami A. Leishmania promastigotes are recognized by the macrophage receptor for advanced glycosylation endproducts. J Exp Med 1987; 166: 1377-1389.
13. Nathaniel RP, Horwitz MA. Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors. J Exp Med 1987; 166: 1377-1389.
14. Vlandoianu IR, Chang HR, Pechere JC. Expression of host resistance to Salmonella typhi and Samonella typhimurium: bacterial survival within macrophages of murine and human origin. Microb Pathogen 1990; 8: 83-90.
15. Law SK, Levine RP. Interaction between the third complement protein and cell surface macromolecules. Proc Natl Acad Sei USA 1977; 74: 2701-2705.
16. Law SK, Fearon DT, Levine RP. Action of the C3b-inactivator on cell bound C3b. J Immunol 1979; 122: 759-765.
17. Ross GD, Yount WJ, Walport MJ, Winfield JB, Parker CJ, Fuller CR, Taylor RP, Myones BL, Lachmann PJ. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptor) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/ or complement activation. J Immunol 1985; 135: 2005-2014.
18. Ross GD, Medof ME. Membrane complement receptors specific for bound fragments of C3. Adv Immunol 1985; 37: 217-267.
19. Fearon DT. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocytes, polymorphonuclear leukocytes, B lymphocytes, and monocytes. J Exp Med 1980; 152: 20-30.
20. Hynes RO. Integrins: a family of cell surface receptors. Cell 1987; 48: 549-554.
21. Anderson DC, Springer TA. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA1, and p150,95 glycoproteins. Annu Rev Med 1987; 38: 175-194.
22. Grossman N, Joiner KA, Frank MM, Leive L. C3b binding, but not its breakdown, is affected by the structure of the O-antigen polysaccharide in lipopolysacccharidefrom Salmonellae. J Immunol 1986; 136: 2208-2215.
23. Ross GD, Newman SL, Lambris JD, Devery-Pocius JE, Cain JA, Lachmann PJ. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for B and H, complement receptors, and bovine conglutinin. J Exp Med 1983; 158: 334-352.
24. Gil m ore BJ, Retsinas EM, Lorenz JS, Hostetter MK. An iC3b receptor on Candida alblcans: Struct u re, function, and correlates for pathogenicity. J Infect Dis 1988; 157: 38-46.
25. Van Strijip JAG, Russell DG, Tuomanen E, Brown EJ, Wright SD. Ligand specificity of purified complement receptor type three (CD11b/CD18, am β2, Mac-1). Indirect effect of an Arg-Gly-Asp (RGD) sequence. J Immunol 1993; 151: 3324-3336.
26. Ikewaki N, Tamauchi H, Inoko H. Modulation of cell surface antigens and regulation of phagocytic activity mediated by CD11b in the monocyte-like cell line U937 in response to lipopolysaccharide. Tissue Antigens 1993; 42: 125-132.
27. Wright SD, Licht M R, Craigmyle LS, Silverstein SC. Communication between receptors for different ligands on a single cell: ligation of fibronectin receptors induces a reversible alteration in the function of complement receptors on cultured human monocytes. J Cell Biol 1984; 99: 336-339.
28. Dransfield I, Cabanas C, Craig A, Hogg N. Divalent cation regulation of the function of the leukocyte integrin LFA-1. J Cell Biol 1992; 116: 219-226.
29. Hermanowski A, Van Strijip JAG, Swiggard WJ, Wright SD. Integrin modulating factor-1: a lipid that alters the function of leukocyte integrins. Cell 1992; 68: 341.
30. Wright SD, Silverstein SC. Tumor-promoting phorbol esters stimulate C3b and C3b' receptor mediated phagocytosis in cultured human monocytes. J Exp Med 1982; 156: 1149-1164.
31. Zhou M, Brown EJ. Leukocyte response integrin and integrin-associated protein act as a signal transduction unit in generation of a phagocyte respiratory burst. J Exp Med 1993; 178: 1165-1174.
32. Hazenbos WLW, Van den Berg BM, Van Furth R. Very late antigen-5 and complement receptor type 3 cooperatively mediate the interaction between Bordetella pertussis and human monocytes. J Immunol 1993; 151:6274-6282.
33. Wright SD, Reddy PA, Jong MTC, Erickson BW. C3bi receptor (complement receptor type 3) recognizes a region of complement protein C3 containing the sequence Arg-Gly-Asp. Proc Natl Acad Sei USA 1987; 84: 1965-1968.
34. Fleming JC, Pahl HL, Gonzalez DA, Smith TF, Tenen DG. Structural analysis of the CD11b gene and phylogenetic analysis of the α-integrin gene family demonstrate remarkable conservation of genomic organization and suggest early diversification during evolution. J Immunol 1993; 150: 480-190.
35. Pytela R. Amino acid sequence of the murine Mac-1 alpha chain reveals homology with the integrin family and an additional domain related to Von Willebrand factor. EM BO J 1988; 7: 1371.
36. Micklem KJ, Sim RB. Isolation of complement-fragment iC3b-binding proteins by affinity chromatography. The identification of p150,95 as an iC3b-binding protein. Biochem J 1985; 231: 233-236.
37. Bilsmand CA, Diamond MS, Springer TA. The leukocyte integrin p150,95 (CD11c/CD18) as a receptor for iC3b. Activation by a heterologous beta subunit and localization of ligand recognition site to the I domain. J Immunol 1994; 152: 4582-4589.
38. Hazoit AA, Chen S, Ferrero E, Low MG, Silber R, Goyert SM. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidyl-inositol linkage. J Immunol 1988; 141 : 547-552.
39. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathisom JC. CD14, a receptor for complexes of lipopolysaccharide (IPS) and LPS-binding protein. Science 1990; 249: 1431-1433.
40. Hiemstra PS, Van Furth R. Antimicrobial mechanisms: polypeptides of mononuclear phagocytes. In Zwilling BS, Eisenstein TK, eds. Macrophage-pathogen interactions. 1994; pp197-202. New York, NY: Marcel Dekker, Inc.
41. Ishibashi Y, Arai T. Susceptibility of Salmonella typhlmurium and Salmonella typhi to oxygen metabolites. FEMS Microbiol Immunol 1989; 47: 279-284.
42. Chateau MT, Caravano R. Infection of differentiated U937 cells by Salmonella typhlmurium: absence of correlation between oxidative burst and antimicrobial defence. FEMS Immunol Med Microbiol 1993; 7: 111-118.
43. 2 diffusion. FEMS Immunol Med Microbiol. 1996; 13: 19-28.
44. Joiner KA, Ganz T, Albert J, Rotrosen D. The opsonizing ligand on Salmonella typhimurium influences incorporation of specific, but not azurophil, granule constituents into neutrophil phagosomes. J Cell Biol 1989; 109: 2771-2782.
45. Ishibashi Y, Arai T. Mutant of Salmonella typhimurium lacking the inhibitory function for phagosome-lysosome fusion in murine macrophages. Microb Pathog 1992; 13: 317-323.
46. Kress Y, Bloom BR, Witter M, Rowen A, Tanowitz H. Resistance of Trypanosoma cruzio killing by macrophages. Nature 1975; 257: 394-396.
47. Kinoshita T, Takeda J, Hong K, Kozono H, Sasaki H, Inoue K. Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J Immunol 1988; 140: 3066-3072.
48. Sasakawa C, Yoshikawa M. A series of Tn5 variants with various drug-resistance markers and suicide vector for transposon mutagenesis. Gene 1987; 56: 283-288.
49. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; 21, suppl. 97: 77-89.
50. Li CY, Lam KW, Yam LT. Esterases in human leukocytes. J Histochem Cytochem 1973; 21:1.
51. Becker S, Warren MK, Haskill S. Colony-stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures. J Immunol 1987; 139: 3703-3709.
52. Lissner CR, Swanson RN, O'Brien AD. Genetic control of t he innate resistance of m ice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro. J Immunol 1983; 131: 3006-3013.
53. Ishibashi Y, Arai T. Role of the complement receptor type 1 (CR1) and type 3 (CR3) on phagocytosis and subsequent phagosome-lysosome fusion in Salmonella-infected murine macrophages. FEMS Microbiol Immunol 1990; 64: 89-96.
54. Shiao M-F, Rowland H. Bactericidal and opsonizing effects of normal serum on mutant strains of Salmonella typhimurium. Infect Immun 1985; 49: 647-653.
55. Gulig PA, Curtiss R III. Plasm id-associated virulence of Salmonella typhimurium. Infect Immun 1987; 55: 2891-2901.
56. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27: 493-197.